Taika Capital LP Takes Position in Encompass Health Co. (NYSE:EHC)

Taika Capital LP acquired a new position in shares of Encompass Health Co. (NYSE:EHC) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,798 shares of the company’s stock, valued at approximately $351,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares in the last quarter. Avior Wealth Management LLC purchased a new stake in shares of Encompass Health during the third quarter worth $40,000. Tompkins Financial Corp purchased a new stake in shares of Encompass Health during the fourth quarter worth $46,000. V Square Quantitative Management LLC raised its holdings in shares of Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after acquiring an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc purchased a new stake in shares of Encompass Health during the third quarter worth $68,000. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Trading Down 0.5 %

Shares of NYSE:EHC opened at $99.20 on Monday. The company has a market cap of $9.99 billion, a P/E ratio of 22.24, a P/E/G ratio of 2.31 and a beta of 0.92. The stock’s 50-day moving average is $96.95 and its 200-day moving average is $96.80. Encompass Health Co. has a 52-week low of $74.27 and a 52-week high of $104.55. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities research analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is presently 15.25%.

Analyst Ratings Changes

Several analysts recently issued reports on the company. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Royal Bank of Canada restated an “outperform” rating and set a $110.00 target price on shares of Encompass Health in a report on Tuesday, February 11th. Barclays raised their target price on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, February 7th. KeyCorp raised their target price on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Monday, February 10th. Finally, StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and an average price target of $107.67.

Insider Buying and Selling

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.10% of the stock is owned by company insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.